We create value for our clients through expertise in research, interpretation, and communication

Sectors

Pharma & Medical Devices
Healthcare Organisations
Public Sector & Charities
Life Science Startups
Innovation Hubs

Capabilities

Strategy development is the process of defining the direction and actions that an organisation should take to achieve its goals. We work closely with our clients to develop strategies that align with their vision and market realities. The outputs of our work often include strategic plans, roadmaps, and actionable recommendations that guide decision-making and resource allocation. By providing clear, evidence-based strategies, we empower our clients to navigate complex markets, differentiate their offerings, and achieve sustainable growth.
Stakeholder engagement involves identifying, understanding, and effectively communicating with key individuals and groups who have an interest in or can influence the success of a project or product. Our approach to stakeholder engagement includes mapping key stakeholders, developing targeted communication strategies, and facilitating interactions that build trust and support. The outputs include stakeholder maps, engagement plans, and communication materials tailored to each audience. Proactive engagement ensures that client initiatives are well-supported, reducing risks and enhancing the likelihood of successful outcomes.
Market research is the systematic gathering, analysis, and interpretation of information about a market, including insights into potential customers, competitors, and trends. We leverage this capability to provide our clients with data-driven insights that inform critical business decisions. Our research outputs typically include comprehensive reports, market models, and strategic recommendations that are customised to the specific needs of our clients. These insights help our clients understand the market landscape, identify opportunities and threats, and make informed decisions on product development, positioning, and go-to-market strategies, ultimately driving business success.
Launch and commercialisation encompass the activities required to bring a new product or service to market and ensure its commercial success. We support our clients by developing launch plans that include market entry strategies, pricing models, and promotional activities. The outputs often comprise detailed launch strategies, execution plans, and performance metrics. By guiding our clients through the complexities of launching a new product, we help them maximise market impact, achieve rapid uptake, and establish a strong market presence, leading to commercial success.
Medical and scientific communications involve the creation and dissemination of accurate, clear, and impactful content that translates complex scientific data into understandable information for various audiences. We apply this capability by developing a range of materials, including peer-reviewed publications, educational materials, advisory board reports, and congress posters. By ensuring that the science behind a product or service is communicated effectively, we help our clients build credibility, engage stakeholders, and support successful product adoption and market positioning.

Case Studies

Assessing AI Preparedness in Drug Discovery

STAKEHOLDER ENGAGEMENT
We collaborated with the Medicines Discovery Catapult to evaluate the UK drug discovery sector's preparedness for AI integration.

Read More
Improved Equity of Care in Pressure Injury Management

MEDICAL AND SCIENTIFIC COMMUNICATIONS
We provided medical writing support to US-based medical device company Bruin Biometrics, which involved writing up the results of a quality improvement study.

Read More
Defining Value Proposition and Route to Market

MARKET RESEARCH
We worked with a UK-based medical device start-up to assess the clinical and commercial potential of their innovative non-invasive continuous glucose monitor.

Read More
Clinical Insights to Support an Investment Round

STRATEGY DEVELOPMENT
We worked with the team at QV Bioelectronics to obtain opinions from clinicians about the clinical prospects of their treatment for glioblastoma.

Read More
Strategic Planning to Support NHS Sustainability

LAUNCH AND COMMERCIALISATION
We worked with the Centre for Sustainable Healthcare to obtain insights from stakeholders about the product-market fit of CSH’s programmes and the factors influencing their uptake.

Read More
Documenting the Natural History of a Rare Disease

MEDICAL AND SCIENTIFIC COMMUNICATIONS
We worked with the team at Salford Royal Hospital to review the data collected as part of a real‑world data study on the progression of arginase-1 deficiency in adults treated at the hospital.

Read More

Testimonials

“Nexcea’s expertise in manuscript preparation and their ability to interpret our data helped with the successful submission of our study. Their understanding of our research needs was evident from the start. They were always available to assist with revisions and responses to reviewer comments, making the process much smoother for our team. I can recommend their services to anyone seeking support with medical publications.”

Dr Reena Sharma, Consultant Adult Metabolic Medicine, Salford Royal Hospital, Northern Care Alliance
“Nexcea were excellent to work with, and I highly recommend them. As a very early startup, we needed to gather insights from clinicians on our innovative approach to treating glioblastoma. Nexcea identified and interviewed key clinicians in the UK and USA, providing us with valuable information on patient pathways, unmet needs, and how our treatment could integrate with current practices. The feedback was crucial in refining our product development and gave us the validation we needed to successfully raise investment. The process was straightforward, and we gained exactly the insights we were looking for.”

Qasim Akhtar, Head of Business Development, QV Bioelectronics
"I had the pleasure of working with Nexcea on a key publication focused on the impact of Sub-Epidermal Moisture (SEM) technology, particularly its role in detecting pressure ulcers in patients with dark skin tones. Pressure ulcer detection has long been challenging in individuals with darker skin, and Bruin Biometrics' SEM Technology offers a ground-breaking solution by identifying tissue damage before visible signs appear. Paul Riley PhD, and Meg Smith PhD, brought a wealth of expertise, helping us effectively convey the clinical significance of SEM technology. Their ability to translate complex scientific concepts into a compelling and accessible narrative was invaluable. Thanks to their efforts, our publication reached a wide audience and highlighted a crucial advancement in patient care. I highly recommend Nexcea for their deep understanding of life sciences, professionalism, and commitment to delivering impactful results."

Dr Vignesh Iyer, Vice-President, Global Medical Affairs and Market Access, Bruin Biometrics
“Nexcea expertly supported drafting our report for Innovate UK, which involved coordinating interviews with industry professionals. Their exceptional organisational skills, clear communication, and ability to navigate complex project requirements were instrumental in delivering a high-quality outcome. Nexcea's professionalism and efficiency made the entire process smooth and successful.”

Dr Mark Pinches, Head of Informatics, Medicines Discovery Catapult
"It was a pleasure to work with Nexcea, they have extensive knowledge of the pharmaceutical industry and a great understanding of digital health technology. We wanted to explore applications of our AI technology in the life science industry. Nexcea identified and arranged meetings with multiple stakeholders from different companies in the industry, providing us with valuable information on pharma workflow, unmet needs, and how our AI could support current practices. The feedback was crucial in refining our product development."

Dr Keith Tsui, CEO, Medwise.ai
“It was really helpful working with Nexcea on understanding the market for some of our services. Not only was the report helpful to steer our approach but we were so involved in the process that our team learned some of the skills needed and we’ve been able to repeat the exercise under our own steam since. We certainly would recommend.”

Hazel Walsh, Clinical Transformation Programme Manager, The Centre for Sustainable Healthcare
“My experience with Nexcea has been exceptional. They excelled in devising a structured plan for us to assess the value of integrating clinical biomarker analysis into our services at Medicines Discovery Catapult. In addition to assembling a thorough plan, they successfully coordinated interviews, facilitated an advisory group, and constructed a comprehensive report containing decisive findings and recommendations for future steps.”

Gayle Marshall, Head of Biomarkers, Medicines Discovery Catapult
“Nexcea’s insights were crucial for our non-invasive continuous glucose monitor. The team promptly gathered feedback from specialists and provided NHS procurement guidance and economic analysis confirming our product's market fit and strategic NHS adoption path. Thank you for your exceptional support.”

CEO, UK-Based Medical Device Startup